Novavax Inc. says it has reached an agreement with the Canadian government to supply up to 76 million doses of its possible vaccine for COVID-19.The company announced the agreement Monday morning, hours before Prime Minister Justin Trudeau was due to make an announcement of his own, following a visit with the National Research Council of Canada in Montreal.Novavax — a biotechnology company that develops vaccines for serious infectious diseases — said in a statement that it expects to finalize the advanced purchase agreement “as early as the second quarter of 2021.” Canadians could join clinical trials for new COVID-19 vaccine, says researcher Novavax’s vaccine (NVX-CoV2373) is currently in its second phase of clinical trials.